The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): A comprehensive review of 116 reported patients

Iodine-131 metaiodobenzylguanidine (131I-MIBG), a radiopharmaceutical agent used for scintigraphic localization of pheochromocytomas, has been employed to treat malignant pheochromocytomas since 1983 in a few specialized centers around the world. We review our clinical experience together with the p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of endocrinological investigation 1997-12, Vol.20 (11), p.648-658
Hauptverfasser:	LOH, K.-C, FITZGERALD, P. A, MATTHAY, K. K, YEO, P. P. B, PRICE, D. C
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Iodobenzylguanidine - adverse effects 3-Iodobenzylguanidine - analysis 3-Iodobenzylguanidine - therapeutic use Adolescent Adrenal Gland Neoplasms - pathology Adrenal Gland Neoplasms - therapy Adult Antineoplastic Agents - therapeutic use Biological and medical sciences Endocrine glands Female Humans Iodine Radioisotopes Male Medical sciences Middle Aged Paraganglioma, Extra-Adrenal - secondary Paraganglioma, Extra-Adrenal - therapy Pheochromocytoma - secondary Pheochromocytoma - therapy Radiopharmaceuticals - therapeutic use Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!